June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections. Originally approved in 2012 as a treatment for people with HIV that no longer responded to several… Read more
June 18, 2025 — The FDA has approved a first-of-its-kind treatment for a rare genetic condition that causes frequent, unpredictable, and painful swelling in different parts of the body. The drug, known as garadacimab but sold… Read more
May 30, 2025 – The FDA has approved the first-ever meningococcal vaccine for babies as young as 6 weeks old. Sanofi Pasteur’s quadrivalent MenQuadfi shot was first cleared in 2020 for adults and children ages 2… Read more
May 2, 2025 — The FDA has approved a new treatment for generalized myasthenia gravis (gMG), a disease that causes severe muscle weakness, faster muscle fatigue, and difficulty in speaking and swallowing. It offers long-lasting option… Read more
Vonvendi is a lab-made version of von Willebrand factor (VWF), a protein your body needs for blood to clot. Affecting more than 3 million people in the U.S, von Willebrand disease (VWD) is a common… Read more
Gazyva (obinutuzumab) is a lab-made antibody medication used for treating certain blood cancers. The FDA recently approved the combined use of Gazyva and standard therapy in adults having an active kidney disease known as lupus… Read more
Keytruda Qlex is a new form of pembrolizumab, a cancer-fighting lab-made antibody that helps your immune system find and attack cancer cells. Unlike the original 30-minute intravenous (IV) drip, the Keytruda Qlex shot is a… Read more
Jascayd (nerandomilast) is a new oral medicine approved to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is a rare and serious condition that causes scarring (fibrosis) in the lungs that worsens over time, making… Read more
Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as you get older. It’s the first and only… Read more
Leqvio (inclisiran) is a prescription injection that helps lower levels of low-density lipoprotein cholesterol (LDL), often called “bad” cholesterol, which is a major risk factor for heart disease, heart attack, and stroke. It works by blocking… Read more